NURS 6630N Midterm Exam
NURS 6630N Week 6 Midterm EXAM
NURS-6630N: Psychopharmacologic Approaches
to Treatment of Psychopathology.
Latest New Versions
76 Q & A in Each Version, Verified and 100 % Correct|
Best document for Exam
Absolute Satisfaction
, Course NURS-6630A-2/NURS-6630N-2/NURS-6630D-2/NURS-6630C-2-
Approaches to Treatment-2021-Winter-QTR-Term-wks-1-thru-11-
(11/29/2021-02/13/2022)-PT27
Test Midterm Exam - Week 6
Started 1/8/22 11:00 AM
Submitted 1/8/22 12:38 PM
Due Date 1/10/22 1:59 AM
Status Completed
Attempt 60 out of 100 points
Score
Time 1 hour, 38 minutes out of 2 hours and 30 minutes
Elapsed
Results Feedback
Displayed
Question 1
Is this a TRUE or FALSE statement? The following patient case is considered an
example of treatment-resistant depression.
B. B. is a 26-year old-female at your clinic today with the diagnosis, “treatment-resistant
depression.” She is currently on Bupropion 300 mg daily and has been at this dose for 6
weeks with no alleviation in depressive symptoms.
She has trialed the following medications in the past with treatment duration listed:
- Paroxetine 40 mg daily for 6 weeks
- Citalopram 20 mg daily for 2 weeks
Response “At least one trial with an antidepressant with established efficacy in
Feedback: MDD (with sufficient duration and doses) is considered to be
adequate antidepressant treatment.”
• Question 2
Ronnie presents to your clinic with tremor, bradykinesia, and rigidity. The symptoms
are very similar to what you would see in a patient with Parkinson’s disease. The
client was prescribed risperidone several weeks ago. What is the reason for
Ronnie’s symptoms?
Response
Feedback:
Risperidone is an antipsychotic that works by blocking dopamine receptors in
the striatum. Dopamine blockade has been associated with the extrapyramidal
symptoms that are seen with antipsychotic usage.
NURS 6630N Week 6 Midterm EXAM
NURS-6630N: Psychopharmacologic Approaches
to Treatment of Psychopathology.
Latest New Versions
76 Q & A in Each Version, Verified and 100 % Correct|
Best document for Exam
Absolute Satisfaction
, Course NURS-6630A-2/NURS-6630N-2/NURS-6630D-2/NURS-6630C-2-
Approaches to Treatment-2021-Winter-QTR-Term-wks-1-thru-11-
(11/29/2021-02/13/2022)-PT27
Test Midterm Exam - Week 6
Started 1/8/22 11:00 AM
Submitted 1/8/22 12:38 PM
Due Date 1/10/22 1:59 AM
Status Completed
Attempt 60 out of 100 points
Score
Time 1 hour, 38 minutes out of 2 hours and 30 minutes
Elapsed
Results Feedback
Displayed
Question 1
Is this a TRUE or FALSE statement? The following patient case is considered an
example of treatment-resistant depression.
B. B. is a 26-year old-female at your clinic today with the diagnosis, “treatment-resistant
depression.” She is currently on Bupropion 300 mg daily and has been at this dose for 6
weeks with no alleviation in depressive symptoms.
She has trialed the following medications in the past with treatment duration listed:
- Paroxetine 40 mg daily for 6 weeks
- Citalopram 20 mg daily for 2 weeks
Response “At least one trial with an antidepressant with established efficacy in
Feedback: MDD (with sufficient duration and doses) is considered to be
adequate antidepressant treatment.”
• Question 2
Ronnie presents to your clinic with tremor, bradykinesia, and rigidity. The symptoms
are very similar to what you would see in a patient with Parkinson’s disease. The
client was prescribed risperidone several weeks ago. What is the reason for
Ronnie’s symptoms?
Response
Feedback:
Risperidone is an antipsychotic that works by blocking dopamine receptors in
the striatum. Dopamine blockade has been associated with the extrapyramidal
symptoms that are seen with antipsychotic usage.
